News
Public · Published
Ashland Inc. (ASH) FY26 Adjusted EBITDA Falls 4% to $385M
Ashland reported fiscal 2026 sales of $1.9 billion, up from $1.8 billion a year earlier, while adjusted EBITDA, a measure of operating earnings, fell 4% to $385 million from $401 million. The company also issued fiscal 2027 guidance, but the release provided no guidance ranges.
Published:
Updated:
What happened
Ashland reported fiscal 2026 sales of $1.9 billion, up from $1.8 billion a year earlier, while adjusted EBITDA, a measure of operating earnings, fell 4% to $385 million from $401 million. The company also issued fiscal 2027 guidance, but the release provided no guidance ranges.
Confirmed
Global impact / market context
Higher sales did not translate into higher operating earnings, suggesting costs or operating performance absorbed the growth. The article identifies lower productivity at the Hopewell site as a key pressure. Improved cash generation, mainly from lower working capital and capital spending, may provide more funds for operations.
Analyst inference
The results are mixed: sales and cash generation increased, but adjusted EBITDA and adjusted EPS fell. The net income swing is less informative about underlying progress because it chiefly reflects the absence of prior-year impairment charges, which are accounting write-downs.
Analyst inference
What to watch
- Ashland issued fiscal 2027 guidance, but the release gave no ranges; any later ranges would help investors assess expected sales and earnings performance. Confirmed
- Watch for evidence that Hopewell productivity improves, since the article identifies weaker output there as a key pressure on adjusted EBITDA. Analyst inference
- Track whether Specialty Additives profit per sale recovers, as the article names margin recovery as a subsequent catalyst for evaluating earnings quality. Analyst inference